Difference between revisions of "Paul McKay"
From QueerBio.com
| Line 15: | Line 15: | ||
Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London. Team member who developed the COVID-19 vaccine in 2020/2021. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue. | Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London. Team member who developed the COVID-19 vaccine in 2020/2021. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue. | ||
| + | |||
| + | ==See Also== | ||
| + | |||
| + | * [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]] | ||
==Further Reading/Research== | ==Further Reading/Research== | ||
Latest revision as of 20:41, 19 September 2021
Country
Great Britain
Birth - Death
Occupation
Scientist
Description
Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London. Team member who developed the COVID-19 vaccine in 2020/2021. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue.
